Roche Reports Strong Revenue Growth in Germany, Pharmaceutical Division Leads GainsSwiss pharmaceutical giant Roche has reported solid financial performance in its German operations for 2025, achieving a 4.7 percent increase in revenue. Pharmaceutical Division Drives GrowthThe pharmaceutical segment was a primary driver of Roche's revenue gains in Germany, posting a 6.3 percent increase to reach 2.2 billion euros. Diagnostics Division Experiences Minor DeclineWhile the pharmaceutical segment showed notable growth, Roche's diagnostics division in Germany experienced a slight decrease in revenue, declining by 1 percent to 909 million euros. This uptick underscores Germany's strategic importance as a hub for technology, production, and export within Roche's global structure. The company's sustained investments and export activities further cement Germany's position as a critical node in Roche's global network.

Source: The Munich Eye March 06, 2026 22:12 UTC